Refine Your Results

Click below to filter your search results

"This Month"Undo

Search Results

Results 1–3 of 3
Sort By: Relevance| Date| Title

The U.S. Food and Drug Administration (FDA) has updated its drug safety information for fluoroquinolone antibiotics to include the rare but serious risk of aortic ruptures or tears in certain patients.


Committee Opinion Number 794, November 2019

ABSTRACT: Postpartum hemorrhage causes approximately 11% of maternal deaths in the United States and is the leading cause of death that occurs on the day of birth. Importantly, 54–93% of maternal deaths due to obstetric hemorrhage may be preventable. Studies that have evaluated factors associated with identification and treatment of postpartum hemorrhage have found that imprecise health care provider estimation of actual blood loss during birth and the immediate postpartum period is a leading cause of delayed response to hemorrhage. Although current data do not support any one method of quant...


Committee Opinion Number 793, November 2019

(Replaces Committee Opinion Number 634, June 2015)

ABSTRACT: A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheritance. The most common hereditary cancer syndromes related to women’s cancer include hereditary breast and ovarian cancer syndrome, Lynch syndrome, Li–Fraumeni syndrome, Cowden syndrome, Peutz–Jeghers syndrome, and hereditary diffuse gastric cancer. A hereditary cancer risk assessment is the key to identifying patients and families who may ...


Advertisement

American College of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188
Mailing Address: PO Box 96920, Washington, DC 20024-9998